Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·96 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Cannabis Rescheduling Is Here. What Happens Next? | Hirsh Jain
May 28, 2026
1h 30m 52s
Cannabis Lending After Schedule III with Steven Ernest of Chicago Atlantic
May 14, 2026
1h 04m 32s
Is Cannabis Finally Investable Again? Rescheduling, GTI, Vireo & C21 Deep Dive
Apr 23, 2026
1h 34m 56s
Finding Alpha in Cannabis: Allocation, Debt, and What Actually Works w/ Jerry Derevyanny
Apr 9, 2026
1h 24m 11s
LEEF Q4 2025 Earnings Review: Inside the Transformation with CEO Micah Anderson
Mar 26, 2026
1h 02m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/28/26 |  Cannabis Rescheduling Is Here. What Happens Next? | Hirsh Jain | Cannabis rescheduling is officially here. Now what? This week, Jesse Redmond and Morgan Paxhia welcome back Hirsh Jain to discuss what Schedule III means for the industry, how states are responding, and what comes next. We cover the upcoming adult-use hearings, interstate commerce, export opportunities, Virginia's latest legalization setback, Pennsylvania's outlook, and which operators stand to benefit most from the next phase of cannabis reform. Topics: • Schedule III implementation • Int... | 1h 30m 52s | ||||||
| 5/14/26 |  Cannabis Lending After Schedule III with Steven Ernest of Chicago Atlantic | On this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia sit down with Steven Ernest, Head of Originations at Chicago Atlantic, to discuss how cannabis lending and private credit markets are evolving heading into a potential Schedule III world. Steven gives an update on Chicago Atlantic’s platform today, how cannabis credit has changed over the last 12–18 months, and why periods of industry stress can create compelling opportunities for disciplined lenders. The conversation also ... | 1h 04m 32s | ||||||
| 4/23/26 |  Is Cannabis Finally Investable Again? Rescheduling, GTI, Vireo & C21 Deep Dive | In this Higher Exchanges deep dive, we break down the cannabis sector at a critical moment following 4/20 and renewed momentum around federal rescheduling. Jesse Redmond is joined by Morgan Paxhia and Sammy J to focus on what’s actually changing — and what investors should be paying attention to. Topics Covered: Federal cannabis rescheduling: what just happened and what comes next4/20 recap and what it says about consumer demandGreen Thumb Industries (GTI): best-in-class or fully valued?Vireo... | 1h 34m 56s | ||||||
| 4/9/26 |  Finding Alpha in Cannabis: Allocation, Debt, and What Actually Works w/ Jerry Derevyanny | Where can investors actually find value in cannabis today — and how should they be thinking about the space going forward? In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia are joined by Jerry Derevyanny, Partner at Bengal Capital, for a wide-ranging conversation on capital allocation, alternative investment strategies, and what separates real operators from the rest. We cover: • Where value is emerging today — concentrated vs. broad exposure and where alpha is coming from ... | 1h 24m 11s | ||||||
| 3/26/26 |  LEEF Q4 2025 Earnings Review: Inside the Transformation with CEO Micah Anderson | On this episode of Higher Exchanges, we’re joined by Micah Anderson, CEO of LEEF Brands, to break down the company’s fourth quarter and full year 2025 results and what they signal about the next phase of growth. We cover LEEF’s evolution, including the addition of Salisbury Canyon Ranch, and how vertical integration is driving margin expansion, improved consistency, and stronger cash flow. Q4 marked a clear inflection point, with revenue up nearly 40% year-over-year, gross margins reaching 45... | 1h 02m 39s | ||||||
| 3/12/26 |  Inside the World’s Leading Cannabis Company | Curaleaf CEO Boris Jordan on Rescheduling, Capital Markets, and Consolidation | On today’s episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia sit down with Boris Jordan, Chairman and CEO of Curaleaf, the largest cannabis company in the world. We discuss what may be the most important policy and capital markets moment the industry has seen in years. Boris shares Curaleaf’s perspective on federal rescheduling, what it could change for operators, when it may become final, and whether additional catalysts like SAFER banking, uplisting, or even descheduling could fo... | 59m 05s | ||||||
| 2/27/26 |  Is CBD Back? A Conversation with Bill Morachnick, CEO of Charlotte’s Web | On this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia are joined by Bill Morachnick, CEO of Charlotte’s Web, to explore whether the CBD category is entering a true restart or simply experiencing another policy-driven moment. The conversation covers the evolution of CBD since the 2018–2019 boom, the emerging Medicare/CMMI reimbursement channel, and how regulatory momentum could reshape access, adoption, and total addressable market — particularly among senior consumers. Bill sha... | 1h 15m 22s | ||||||
| 2/12/26 |  Five Hard Questions Facing Cannabis Investors | In today’s episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia tackle five of the toughest questions shaping the next phase of the cannabis industry. Will Schedule III trigger a lasting cannabis bull market?Will federal hemp restrictions remain in place through November 2026?Will two of Pennsylvania, Virginia, and Florida legalize adult use and restart growth?Will three of today’s Tier One operators still be the top five cannabis companies in ten years?And will a U.S. plant-touching ... | 1h 00m 57s | ||||||
| 1/29/26 |  TerrAscend at a Turning Point: Federal Reform, Capital Strategy, and the Path Forward | On this episode of Higher Exchanges, hosts Jesse Redmond and Morgan Paxhia are joined by Jason Wild and Ziad Ghanem of TerrAscend for a timely conversation on where cannabis investing goes next. As federal reform approaches and capital markets begin to reawaken, the group explores how operators and investors are positioning for the industry’s next phase. We discuss: Whether this catalyst cycle is truly differentTerrAscend’s perspective on rescheduling and what changes post-reformWhat may come... | 1h 03m 58s | ||||||
| 1/8/26 |  Cannabis Rescheduling: A Tailwind for the Cannabis 2.0 M&A Cycle | Higher Exchanges is presented by Flowhub. Following the federal Executive Order to move cannabis from Schedule I to Schedule III, the cannabis industry may be entering the early stages of a new M&A cycle. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia are joined by Dai Trong, Managing Director at Arlington Capital Partners, to discuss how rescheduling could accelerate consolidation, unlock capital, and reshape strategic behavior across the sector. After years o... | 1h 02m 04s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/19/25 |  Cannabis Schedule III Breakdown: What It Means for Policy, Capital Markets, and Investors | This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare... | 1h 15m 08s | ||||||
| 12/11/25 |  2025 Cannabis Investing Review & 2026 Preview | We’re fresh back from MJBiz and breaking down everything: the people we saw, the energy on the floor, standout moments, and yes—Jesse’s run-in with the “Angry” hot chicken. Each of us shares the surprises that caught our attention this year, along with our biggest learnings from the conference. From there, we shift into a forward-looking conversation about 2026: what to expect, how the hemp ban reshapes TAM, why Curaleaf exiting the hemp category matters, and which opportunities emerge (like ... | 1h 38m 20s | ||||||
| 11/21/25 |  What the Hemp Is Going On? — with Whitt Steineker | Today on Higher Exchanges, Jesse and Morgan sit down with Whitt Steineker, Partner at Bradley Arant Boult Cummings LLP, to break down the major regulatory shifts impacting hemp, cannabis, and the broader U.S. market. We cover: What just happened to the U.S. hemp market — why it happened, what it means, and when enforcement may hit.How new hemp rules affect state-licensed cannabis — potential opportunities, risks, and implications for federal reform.The future of industrial hemp — genetics, fa... | 1h 07m 52s | ||||||
| 11/5/25 |  Q3 Earnings Review with LEEF Brands CEO Micah Anderson | In this episode, we sit down with Micah Anderson, CEO of LEEF Brands (CSE: LEEF | OTCQB: LEEEF), to break down the company’s Q3 2025 financial results and what’s driving its turnaround story. LEEF delivered a standout quarter with revenue up 24% year-over-year to $8.4M, gross margins doubling to 45%, and the company generating positive adjusted EBITDA and free cash flow for the first time. We discuss the key drivers behind that performance — from the first successful harvests at Salisbury Can... | 1h 04m 54s | ||||||
| 10/23/25 |  Cannabis Done Right with Jetty CEO Ron Gershoni | In this episode of Higher Exchanges, we sit down with Ron Gershoni, CEO and co-founder of Jetty Extracts — one of California’s longest-standing cannabis brands — to explore what it takes to build, protect, and scale a cannabis brand in today’s challenging market. We cover: 🚀 Jetty’s founding story and lessons from a decade of brand building💨 From the first vape to solventless, pre-rolls, and product innovation🛡 How Jetty navigated “Vape Gate” and built consumer trust through clean products🌱 T... | 58m 37s | ||||||
| 10/9/25 |  Minnesota's New Era with Aaron Edelheit | Minnesota just launched adult-use cannabis sales — and the market could quickly become one of the most lucrative in the U.S. Jesse Redmond and Morgan Paxhia sit down with Aaron Edelheit, CEO of Mindset Capital, to unpack why Minnesota’s cannabis rollout is so unique and what it means for operators, investors, and policy watchers. In this episode: Minnesota’s cannabis history and the adult-use rolloutThe massive cultivation gap (60,000 sq. ft. available vs. 2 million needed)Why Green Thumb, Vi... | 1h 16m 24s | ||||||
| 9/19/25 | The Future of Intoxicating Hemp with Tucker Johnson | What’s really driving the rise of intoxicating hemp—and where is it headed next? In this episode, we sit down with Tucker Johnson, whose career spans CFO roles at Lil Wayne’s cannabis company and the Emerald Cup, Head of Finance & Cannabis Lead at British American Tobacco, and consulting for top hemp operators. Tucker brings a rare perspective from both mainstream finance and the front lines of cannabis. We dig into: 🌿 The 2018 Farm Bill — how it created today’s intoxicating hemp loophole... | 1h 19m 43s | ||||||
| 9/5/25 | Building Momentum with Aaron Miles, CIO of Verano | Join us on Higher Exchanges for an insightful conversation with Aaron Miles, Chief Investment Officer of Verano Holdings Corp., as we dive into the evolving landscape of the cannabis industry. With over 20 years of financial expertise, he shares how Verano continues to navigate challenges and seize opportunities. Q2 2025 Financial Highlights We break down Verano’s latest performance: a 9% year-over-year revenue dip to $202M, with a projected 7% decline for 2025. With 157 dispensaries na... | 1h 15m 47s | ||||||
| 8/22/25 | Elevating the Game with Jamie Medola | We are excited to have Jamie Mendola on the show for the first time. You know Jamie from his leadership roles at AYR, he was a board member at Glass House Brands, and before cannabis, he was an accomplished investor in the hedge-fund world. Here's what we’ll cover: 🚀 First cannabis SPAC (CSAC) in 2017 🏗️ Lessons from Ayr Wellness on M&A & scaling 🌱 Board insights at Glass House Brands ⚠️ Industry pitfalls: over-expansion, bad cap allocation, compliance costs 📊 Sma... | 1h 01m 11s | ||||||
| 8/7/25 | Tier One MSO Earnings – Q2 2025 Highlights | In this episode, we kick things off with a quick market update, highlighting the recent surge in MSOS ETF momentum, institutional inflows, and what’s been driving cannabis stocks higher since late June. We then dive into AYR Wellness’s restructuring agreement—what it means, how the credit bid process works, and why it could set the tone for distressed M&A in the sector. From there, we break down Q2 earnings from the top tier U.S. operators, including: Trulieve – Continued cash generation ... | 1h 38m 00s | ||||||
| 7/22/25 | Know What You Own Starring Scott Grossman | This week on Higher Exchanges, we dive into the chaos and clarity surrounding cannabis reform, capital markets, and hemp regulation. Joining us is Scott Grossman of Turning Point Brands for a timely roundtable on what’s real, what’s noise, and what could actually move the needle. 🔍 Topics include: Schedule 3 speculation: Who’s driving the renewed chatter, and what do Appropriations moves, VA access, and the DEA vote on Terrance Cole really mean?Political chessboard: Will cannabis reform matte... | 58m 38s | ||||||
| 7/10/25 | New York is Rising Starring Jeff Schultz | In this episode, we sit down with leading cannabis attorney Jeff Schultz, Partner at Foley Hoag, to unpack the real story on New York's adult-use market—what’s working, what’s broken, and where the industry goes from here. We cover: 🔹 The Good: - New York’s adult-use cannabis market is scaling fast—projected to hit $1.5–- $2B+ in 2026, up from just $300M in 2023. - National brands like Kiva, STIIIZY, Wyld, and Heavy Hitters are thriving. - Margins look strong 🔸 The Bad: - Limited retail... | 1h 28m 26s | ||||||
| 6/26/25 | Conquering the Universe with Ted Lidie, Founder of Alien Labs | In this episode of Higher Exchanges, we sit down with Ted Lidie, founder of Alien Labs, to talk about building one of California’s most iconic flower brands—and what it takes to scale that success across markets. We cover: 🌱 The Alien Labs origin story and legacy in the 215 era 🤝 Partnering with Connected and navigating Prop 64 🔥 What makes truly great flower—and why it’s harder to grow now 📉 Pricing pressure, quality control, and the reality of California cannabis in 2025 🏜️ Expanding into A... | 1h 08m 43s | ||||||
| 6/19/25 | The Path Forward Starring Sammy J | In this episode of Higher Exchanges, we sit down with Sammy J to break down what it takes to navigate the cannabis market in 2025. With low or negative growth, tightening margins, and shifting consumer behavior, the landscape is forcing operators to get sharper, leaner, and more strategic. We cover: 📉 Pricing, volume, and profitability in today’s market🌴 How tourism is shaping cannabis sales in Nevada🛍️ 2025 consumer spending habits — what’s changed🌱 Greenshoots: where opportunity is showing ... | 1h 22m 57s | ||||||
| 6/5/25 | Conferences, Courts, and Cannabis Updates | In this episode of Higher Exchanges, we cover: 📈 Bitcoin 2025 recap – key takeaways from the Vegas conference🗓️ Benzinga Cannabis Capital Conference preview – what to expect and who’s attending🧾 Earnings review – insights and investor signals from the latest quarterly reports⚖️ BSF update – legal developments and potential implications of the landmark Boies Schiller Flexner lawsuitWe had hemp on the agenda, but ran out of time! We'll be back to cover that "soon".... | 1h 05m 06s | ||||||
Showing 25 of 99
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.